Similarly, as for lung cancer, the result of OS in the PrognoScan dataset supported the conclusion that the OS of lung cancer patients in the MYL5 high-expression expression group was shorter than the MYL5 low-expression group, indicating that MYL5 could be a poor prognostic factor for lung cancer (Figure 3(o)). The gene discussed is MYL5; the disease is lung carcinoma.